Medicare Enrolled

Dr. Mena Abrahim, D.O.

Otolaryngology · Bridgewater, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
245 US HIGHWAY 22 FL 3, Bridgewater, NJ 08807
9087221042
In practice since 2011 (15 years)
NPI: 1457645707 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abrahim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abrahim? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abrahim

Dr. Mena Abrahim is an otolaryngology specialist in Bridgewater, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. Abrahim performed 1,494 Medicare services across 1,185 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abrahim received a total of $2,996 from 31 pharmaceutical and/or device companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in otolaryngology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abrahim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 36% volume in NJ $2,996 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,494
Medicare services
Top 36% in NJ for otolaryngology
1,185
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~100 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
474 $76 $217
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
260 $35 $263
Nasal endoscopy
A diagnostic procedure that uses a thin, lighted tube to examine the inside of the nasal passages.
230 $163 $766
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
194 $92 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
123 $113 $225
Flexible laryngoscopy
A diagnostic exam of the voice box using a flexible endoscope to visualize the larynx.
72 $114 $290
Impacted earwax removal by physician
Removal of impacted earwax from one or both ears by a physician on the same day as audiologic testing.
72 $43 $109
Nasal and throat exam with endoscope
A procedure to visually examine the nose and throat using a thin, flexible tube with a camera. This allows for direct visualization of the internal structures of the upper airway.
50 $101 $320
Middle ear function test
A diagnostic test used to evaluate how well the middle ear is functioning.
19 $13 $63
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,996
Total received (2018-2024)
Avg $428/year across 7 years
Top 17% in NJ for otolaryngology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
161
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,897 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$604
2023
$603
2022
$370
2021
$195
2020
$137
2019
$616
2018
$471

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AERIN MEDICAL INC.
$170
GENZYME CORPORATION
$137
Optinose US, Inc.
$57
Hikma Pharmaceuticals USA
$50
Takeda Pharmaceuticals U.S.A., Inc.
$50
Regeneron Healthcare Solutions, Inc.
$36
Medtronic, Inc.
$30
Grifols USA, LLC
$24
Lilly USA, LLC
$21
Incyte Corporation
$14
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 60.3% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$659
Regeneron Healthcare Solutions, Inc.
$399
GlaxoSmithKline, LLC.
$172
AERIN MEDICAL INC.
$170
ARBOR PHARMACEUTICALS, INC.
$156
Optinose US, Inc.
$154
CSL Behring
$126
SANOFI-AVENTIS U.S. LLC
$99
Intersect ENT, Inc.
$98
Kaleo, Inc.
$97
ALK-Abello, Inc
$92
Novartis Pharmaceuticals Corporation
$89
Stryker Corporation
$88
OptiNose US, Inc.
$78
Takeda Pharmaceuticals U.S.A., Inc.
$66
Hikma Pharmaceuticals USA
$50
Medtronic, Inc.
$47
Acclarent, Inc
$46
Cochlear Americas
$45
Teva Pharmaceuticals USA, Inc.
$43
Grifols USA, LLC
$42
Aerin Medical Inc.
$34
Shire North American Group Inc
$28
Lilly USA, LLC
$21
Smith+Nephew, Inc.
$21
Mylan Specialty L.P.
$15
Incyte Corporation
$14
kaleo, Inc.
$13
Olympus America Inc.
$13
Lannett Company Inc
$11
Glenmark Therapeutics Inc.
$9
Top 3 companies account for 41.1% of all-time payments
Associated products mentioned in payments ›
ACCLARENT NAVWIRE SINUS NAVIGATION GUIDEWIRE · AREXVY · AUVI-Q · Acclarent Aera · Auvi-Q · BREO · C Topical Solution 4 CII · CINQAIR · CIPRODEX · CUVITRU · Coblation - Tonsil Wands · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EBGLYSS · GAMMA · Grastek · Haegarda · Hizentra · NUCALA · NUVENT · Nucleus · OPZELURA · Odactra · Otiprio · Otovel · Ryaltris · SINUVA · STEALTHSTATION S8 PLATFORM · ThunderBeat · VIVAER STYLUS · XOLAIR · Xembify · Xhance
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an otolaryngology specialist in Bridgewater?
Compare otolaryngologists in the Bridgewater area by procedure volume, costs, and industry payment transparency.
Browse otolaryngologists nearby

Geographic Context

Otolaryngologists within 10 mi
121
Per 100K population
35.0
County median income
$135,960
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL - SOMERSET
3.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Abrahim is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of NJ peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Abrahim experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Abrahim performed 474 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abrahim receive payments from pharmaceutical companies?
Yes. Dr. Abrahim received a total of $2,996 from 31 companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abrahim's costs compare to other otolaryngologists in Bridgewater?
Dr. Abrahim's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abrahim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →